Product

Asset design and definition

Pre-determining the future positioning of an asset early in clinical development runs the risk of obsolescence as data emerges and markets evolve. Too late, and any influence over the label, the core constituent of defining product value at launch is lost

SAABOA believes that while defining the specific value of an asset demands focused and fully aligned execution, an actionable positioning strategy can’t be totally rigid and needs to both anticipate and adapt to changing circumstances

ASSET DESIGN & DEFINITION is a cross-functional approach that can be applied at different product lifecycle stages, aligning an asset’s science, payer value, current/ future clinical development, and label into a unified commercial positioning strategy that is differentiating, robust, and flexible